Editorial Comment to False-positive ¹²³I-metaiodobenzylguanidine scan in a patient with renal cell carcinoma: A case of chromophobe renal cell carcinoma oncocytic variant with a complicated clinical course

Affiliations

Editorial

Naoto Kuroda. IJU Case Rep. 2020.

. 2020 Dec 3;4(1):42-43.

doi: 10.1002/iju5.12244. eCollection 2021 Jan.

No abstract available

Conflict of interest statement

The author declares no conflict of interest.

1. Suyama T, Kanesaka M, Fujimoto A et al False‐positive ¹²³I‐metaiodobenzylguanidine scan in a patient with renal cell carcinoma: a case of chromophobe renal cell carcinoma oncocytic variant with a complicated clinical course. IJU Case Rep. 2021; 4: 39–42. - PMC - PubMed
1. Kuroda N, Tanaka A, Yamaguchi T et al Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors. Med. Mol. Morphol. 2013; 46: 49–55. - PubMed
1. Yamaguchi T, Hirota E, Kuroda N. Chromophobe renal cell carcinoma, oncocytic variant: cytological and ultrastructural observations. J. Cytol. 2015; 32: 184–7. - PMC - PubMed
1. Dinney CP, Norman RW. Citralateral pleural effusion secondary to nonmetastatic renal cell carcinoma. J. Urol. 1990; 143: 1002–3. - PubMed
1. Tessemer CS, Barcellos FC, Falchi LC. Pseudo‐Meigs’ syndrome associated to renal pelvic tumor. Int. Braz. J. Urol. 2005; 31: 256–8. - PubMed